Aptamer 学术简报 — neurodegeneration — 2026-11-11

自动生成 by RBTX Aptamer Tracker v0.1。 子主题 neurodegeneration:近 14 天 4 篇命中(aptamer 池 192 篇)。

评分公式:composite = 0.45×log(IF) + 0.35×log(cites_velocity) + 0.10×social + 0.10×recency_bonus;满分 100。


#1 [12.6] Magnetic-assisted catalytic hairpin assembly fluorescent aptasensor for highly sensitive detection of amyloid-beta oligomers as Alzheimer's disease biomarker.

BACKGROUND: The abnormal accumulation of amyloid-beta peptides is a key contributor to Alzheimer's disease. Of these peptides, soluble amyloid-beta oligomers (AβOs) have emerged as potent neurotoxins and early pathological biomarkers. Although AβOs are highly specific biomarkers, their low physiological abundance, structural heterogeneity and ma...


#2 [12.5] CRISPR-enabled ultrasensitive surface-enhanced Raman scattering sensing platform for background-free detection of phosphorylated tau in Alzheimer's disease.

Accurate and ultrasensitive detection of phosphorylated tau at threonine 231 (P-tau231), a pathologically validated early biomarker of Alzheimer's disease (AD), is essential for preclinical diagnosis and longitudinal monitoring. However, blood-based detection remains challenging because of the femtomolar physiological abundance, substantial inte...


#3 [12.3] An Electrochemiluminescence Biosensing Platform Based on a Hydrogel-AAO Nanochannel Membrane for GFAP Detection

Abstract Electrochemiluminescence (ECL) biosensors are widely used for ultrasensitive bioanalysis; however, their practical application is often limited by insufficient interface stability under complex detection conditions. Herein, an integrated hydrogel-AAO membrane (HAM) as a novel composite ion-exchange membrane is developed for constructing...


#4 [8.0] CRISPR-Cas Assays for Protein Detection: Strategies and Clinical Applications.

Measurement of protein biomarkers with high accuracy is critical for disease diagnostics and prognostic monitoring. However, conventional analytical platforms for protein detection suffer from insufficient sensitivity for low-abundance targets and require time-consuming, multi-step workflows. The CRISPR-Cas system is emerging as a powerful tool ...



Methodology